Health Catalyst CCO Kevin Freeman to Depart, Remain as Senior Advisor

Health Catalyst, Inc.

Kevin Freeman will cease serving as Chief Commercial Officer on February 1, 2026.
Company expects to enter a separation agreement and independent contractor agreement for senior advisor role starting February 2, 2026.
Separation benefits under Executive Severance Plan as summarized in May 2025 proxy statement.
Transition intended to enable smooth handover of commercial responsibilities.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.